13F Data
13F filer · CIK 1839209

Darwin Global Management, Ltd.

ST. HELIER, Y9 · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$3.8B
$-10.4M vs prior
Positions
5
New / sold out
0 / 1
Added / reduced
3 / 2
Turnover
28.9%
buys $1.6B · sells $1.1B
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedREVOLUTION MEDICINES INC+8,418,804+380.8%+$1.6B
AddedABIVAX SA+152,926+4.4%+$14.7M
AddedBELITE BIO INC+19,807+0.6%+$2.9M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedINSMED INC-10,374,021-61.7%$-1.1B
ReducedROIVANT SCIENCES LTD-50,000-0.7%$-1.7M
Sold outDIANTHUS THERAPEUTICS INC-17,357-100.0%$-1.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $358.4MQ1 2021: $510.7MQ2 2021: $619.9MQ3 2021: $543.3MQ4 2021: $654.6MQ1 2022: $110.2MQ2 2022: $188.2MQ3 2022: $66.4MQ4 2022: $160.6MQ1 2023: $365.6MQ2 2023: $611.7MQ3 2023: $284.2MQ4 2023: $509.5MQ1 2024: $751.2MQ2 2024: $859.5MQ3 2024: $1.2BQ4 2024: $1.1BQ1 2025: $1.5BQ2 2025: $2.4BQ3 2025: $3.6BQ4 2025: $4.9BQ1 2026: $3.8BQ2 2026: $3.8B
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1REVOLUTION MEDICINES INCCOM10,629,822$2.0B54.45%
2INSMED INCCOM PAR $.016,431,163$673.6M17.91%
3BELITE BIO INCSPONSORED ADS3,077,219$456.6M12.14%
4ABIVAX SASPONSORED ADS3,621,583$348.2M9.26%
5ROIVANT SCIENCES LTDSHS6,747,300$234.3M6.23%